Immutep Limited (NASDAQ:IMMP) went up by 6.29% from its latest closing price compared to the recent 1-year high of $7.95. The company’s stock price has collected 10.42% of gains in the last five trading sessions. Press Release reported 2 hours ago that Immutep Achieves Fast Track Designation From US FDA For Efti, A Soluble Lag-3 Protein, In First Line Recurrent/Metastatic Head & Neck Cancer
Is It Worth Investing in Immutep Limited (NASDAQ :IMMP) Right Now?
Opinions of the stock are interesting as 5 analysts out of 5 who provided ratings for Immutep Limited declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $6.64. IMMP currently public float of 61.48M and currently shorts hold a 0.25% ratio of that float. Today, the average trading volume of IMMP was 2.58M shares.
IMMP’s Market Performance
IMMP stocks went up by 10.42% for the week, with a monthly jump of 29.27% and a quarterly performance of 1.92%, while its annual performance rate touched 340.99%. The volatility ratio for the week stands at 5.70% while the volatility levels for the past 30 days are set at 8.15% for Immutep Limited. The simple moving average for the period of the last 20 days is 14.23% for IMMP stocks with a simple moving average of 55.85% for the last 200 days.
Analysts’ Opinion of IMMP
Many brokerage firms have already submitted their reports for IMMP stocks, with B. Riley FBR repeating the rating for IMMP by listing it as a “Buy.” The predicted price for IMMP in the upcoming period, according to B. Riley FBR is $7.75 based on the research report published on September 28th of the previous year 2018.
Maxim Group, on the other hand, stated in their research note that they expect to see IMMP reach a price target of $5, previously predicting the price at $7. The rating they have provided for IMMP stocks is “Buy” according to the report published on February 15th, 2018.
IMMP Trading at 13.85% from the 50-Day Moving Average
After a stumble in the market that brought IMMP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -57.48% of loss for the given period.
Volatility was left at 8.15%, however, over the last 30 days, the volatility rate increased by 5.70%, as shares surge +25.89% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +7.90% upper at present.
During the last 5 trading sessions, IMMP rose by +10.72%, which changed the moving average for the period of 200-days by +217.66% in comparison to the 20-day moving average, which settled at $2.99. In addition, Immutep Limited saw 1.27% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for IMMP
Current profitability levels for the company are sitting at:
- -284.85 for the present operating margin
The net margin for Immutep Limited stands at -179.90. The total capital return value is set at -57.34, while invested capital returns managed to touch -36.28.
When we switch over and look at the enterprise to sales, we see a ratio of 11.53, with the company’s debt to enterprise value settled at 0.58. The receivables turnover for the company is 1.74 and the total asset turnover is 0.17. The liquidity ratio also appears to be rather interesting for investors as it stands at 9.26.